Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jul 21, 2014; 20(27): 8783-8789
Published online Jul 21, 2014. doi: 10.3748/wjg.v20.i27.8783
Published online Jul 21, 2014. doi: 10.3748/wjg.v20.i27.8783
Table 1 Summary of studies investigating colorectal cancer as a risk factor in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease
Ref. | Location | IBD-PSC patients (n) | Colorectal neoplasms (n) | Matched controls? | Study type | Is IBD-PSC a risk for CRC? |
[24] | The Netherlands | IBD (126) | CRC (16) | No | Retrospective | Yes |
[9] | Belgium | IBD (107) | CRC (10) | No | Retrospective | Yes |
[12] | Sweden | IBD (152) | CRC/Dys (3) | No | Retrospective | No |
[31] | Germany | IBD (120) | CRC (7) | No | Prospective | Only with dominant stenosis |
[28] | Argentina | UC (39) | CRC (7) | Yes | Prospective | Yes |
[30] | United States | UC (50) | N/S | Yes | Retrospective | No |
[32] | Sweden | CD (28) | CRC/Dys (9) | Yes | Retrospective | Yes |
[33] | United Kingdom | CD (35) | Dys (1) | No | Retrospective | No |
- Citation: Wang R, Leong RM. Primary sclerosing cholangitis as an independent risk factor for colorectal cancer in the context of inflammatory bowel disease: A review of the literature. World J Gastroenterol 2014; 20(27): 8783-8789
- URL: https://www.wjgnet.com/1007-9327/full/v20/i27/8783.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i27.8783